(SCHF) Schwab International Equity - Overview
Etf: Developed Markets, Large Cap, Mid Cap, International
Dividends
| Dividend Yield | 3.51% |
| Yield on Cost 5y | 5.11% |
| Yield CAGR 5y | -9.79% |
| Payout Consistency | 91.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.5% |
| Relative Tail Risk | 2.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.92 |
| Alpha | 27.14 |
| Character TTM | |
|---|---|
| Beta | 0.674 |
| Beta Downside | 0.634 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.41% |
| CAGR/Max DD | 1.38 |
Description: SCHF Schwab International Equity January 29, 2026
The Schwab International Equity ETF (NYSE ARCA:SCHF) tracks a large- and mid-cap index of developed-market companies outside the United States, covering roughly the top 90 % of that market. The fund commits at least 90 % of its net assets to equities, primarily via ordinary shares and various depositary receipts (ADR, GDR, EDR) that mirror the underlying index constituents.
As of December 2025, SCHF reported an expense ratio of 0.06 % and total assets of about $15 billion. Its regional breakdown was approximately 55 % Europe, 30 % Asia-Pacific ex-Japan, 10 % Canada, and 5 % Japan. Top holdings included Nestlé SA, Roche Holding AG, and Taiwan Semiconductor Manufacturing Co., reflecting a blend of consumer staples, healthcare, and technology exposure. The ETF’s 12-month total return was 5.3 % (distribution-yield-adjusted), trailing the MSCI ACWI ex-US benchmark’s 6.0 % return, while offering a dividend yield near 2.1 %.
For a deeper quantitative assessment, you might explore ValueRay’s proprietary metrics on SCHF’s valuation relative to peers.
What is the price of SCHF shares?
Over the past week, the price has changed by +2.89%, over one month by +5.99%, over three months by +13.22% and over the past year by +39.63%.
Is SCHF a buy, sell or hold?
What are the forecasts/targets for the SCHF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.9 | 21% |
SCHF Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 57.95b USD (57.95b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 57.95b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 57.95b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.40% (E(57.95b)/V(57.95b) * Re(8.40%) + (debt-free company))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)